Bash Biotech Inc.

Bash Biotech is dedicated to revolutionizing the treatment of neurological and kidney diseases. Their innovative approach leverages artificial intelligence and systems biology to unravel the intricate relationship between the host and the oral/gut microbiome. By integrating multi-omics data, Bash Biotech aims to identify promising drug targets, discover novel biomarkers for disease prognosis, and repurpose existing drugs for new therapeutic applications. Their pipeline includes several promising drug candidates. These compounds are being developed to target specific pathways involved in neurological and kidney diseases. To accelerate their research, Bash Biotech has created three innovative platforms: InetModels 2.0 is an interactive database and visualization tool for multi-omics data, the Human Gut Microbiome Atlas is a comprehensive resource for studying the human gut microbiome, and GutMicroNet is an interactive platform for exploring gut microbiome interactions.

Jobs:

News: